Treatment for pancreatic cancer is varied and can include surgery, chemotherapy, radiation, and newer approaches like ...

BOCA RATON, FL / ACCESS Newswire / November 20, 2025 / Empyrean Medical Systems, a pioneer in next-generation radiation oncology technology, today announced a strategic partnership with Thrive Pet ...

This story was produced by the State College regional bureau of Spotlight PA, an independent, nonpartisan newsroom dedicated ...

Jay Leno, whose longtime wife, Mavis Leno, suffers from dementia, opened up about his caretaking journey during an interview ...

Louvain-la-Neuve, Belgium, 20 November 2025 - IBA (Ion Beam Applications SA), the world leader in particle accelerator ...

Louvain-la-Neuve, Belgium, 20 November 2025 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, shares its business update for the third quarter of 2025. Group Overv ...

Following the first Phase 3 study of HyBryte(TM) for the treatment of CTCL, the FDA and the EMA indicated that they would require a second successful Phase 3 trial to support mark ...

FLASH2 study Blinded Response Rate to Date Exceeds Trial Estimate PRINCETON, N.J., Nov. 19, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix ...

FLASH2 study  Blinded Response Rate to Date Exceeds Trial Estimate PRINCETON, N.J., Nov. 19, 2025 /PRNewswire/ -- ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...

A look at how Dr. Hadiyah-Nicole Green transformed personal loss into a groundbreaking laser and nanoparticle treatment that showed complete tumor regression in mice with no side effects.